Skip to main content
Erschienen in: Rheumatology International 9/2013

01.09.2013 | Short Communication

Folate usage in MTX-treated juvenile idiopathic arthritis (JIA) patients is inconsistent and highly variable

verfasst von: Gil Amarlilyo, Ornella J. Rullo, Deborah K. McCurdy, Jennifer M. P. Woo, Daniel E. Furst

Erschienen in: Rheumatology International | Ausgabe 9/2013

Einloggen, um Zugang zu erhalten

Abstract

Folate supplementation is widely accepted and utilized for the prevention of adverse events in juvenile idiopathic arthritis (JIA) patients who are treated with methotrexate. Despite the widespread use of folate supplementation, there is a lack of convincing evidence to support the role of folate in the enhancement of methotrexate efficacy and the prevention of methotrexate-related adverse events. In order to understand current practices used by experts, we surveyed 214 pediatric rheumatologists around the globe. Seventy-one unique folate supplementation regimens were reported for this study. Results indicated that folate supplementation (either in the form of folic acid or folinic acid) is inconsistent and highly variable within the United States as well as between the United States and other countries. This level of variability is often associated with lack of evidence and emphasizes the need for well-designed clinical trials to support a rational folate supplementation regimen in patients with JIA who are treated with methotrexate.
Literatur
1.
Zurück zum Zitat Giannini EH, Brewer EJ, Kuzmina N, Shaikov A, Maximov A, Vorontsov I et al (1992) Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children’s Study Group. N Engl J Med 326:1043–1049PubMedCrossRef Giannini EH, Brewer EJ, Kuzmina N, Shaikov A, Maximov A, Vorontsov I et al (1992) Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children’s Study Group. N Engl J Med 326:1043–1049PubMedCrossRef
2.
Zurück zum Zitat Becker ML, Rosé CD, Cron RQ, Sherry DD, Bilker WB, Lautenbach E (2010) Effectiveness and toxicity of methotrexate in juvenile idiopathic arthritis: comparison of 2 initial dosing regimens. J Rheumatol 37:870–875PubMedCrossRef Becker ML, Rosé CD, Cron RQ, Sherry DD, Bilker WB, Lautenbach E (2010) Effectiveness and toxicity of methotrexate in juvenile idiopathic arthritis: comparison of 2 initial dosing regimens. J Rheumatol 37:870–875PubMedCrossRef
3.
Zurück zum Zitat Hunt PG, Rose CD, McIlvain-Simpson G, Tejani S (1997) The effects of daily intake of folic acid on the efficacy of methotrexate therapy in children with juvenile rheumatoid arthritis. A controlled study. J Rheumatol 24:2230–2232PubMed Hunt PG, Rose CD, McIlvain-Simpson G, Tejani S (1997) The effects of daily intake of folic acid on the efficacy of methotrexate therapy in children with juvenile rheumatoid arthritis. A controlled study. J Rheumatol 24:2230–2232PubMed
4.
Zurück zum Zitat Hashkes PJ, Balistreri WF, Bove KE, Ballard ET, Passo MH (1997) The long-term effect of methotrexate therapy on the liver in patients with juvenile rheumatoid arthritis. Arthritis Rheum 40(12):2226–2234PubMedCrossRef Hashkes PJ, Balistreri WF, Bove KE, Ballard ET, Passo MH (1997) The long-term effect of methotrexate therapy on the liver in patients with juvenile rheumatoid arthritis. Arthritis Rheum 40(12):2226–2234PubMedCrossRef
5.
Zurück zum Zitat Gutierrez-Ureña S, Molina JF, García CO, Cuéllar ML, Espinoza LR (1996) Pancytopenia secondary to methotrexate therapy in rheumatoid arthritis. Arthritis Rheum 39(2):272–276PubMedCrossRef Gutierrez-Ureña S, Molina JF, García CO, Cuéllar ML, Espinoza LR (1996) Pancytopenia secondary to methotrexate therapy in rheumatoid arthritis. Arthritis Rheum 39(2):272–276PubMedCrossRef
6.
Zurück zum Zitat Cron RQ, Sherry DD, Wallace CA (1998) Methotrexate-induced hypersensitivity pneumonitis in a child with juvenile rheumatoid arthritis. J Pediatr 132(5):901–902PubMedCrossRef Cron RQ, Sherry DD, Wallace CA (1998) Methotrexate-induced hypersensitivity pneumonitis in a child with juvenile rheumatoid arthritis. J Pediatr 132(5):901–902PubMedCrossRef
7.
Zurück zum Zitat Morgan SL, Baggott JE, Vaughn WH, Young PK, Austin JV, Krumdieck CL et al (1990) The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis. Arthritis Rheum 33:9–18PubMedCrossRef Morgan SL, Baggott JE, Vaughn WH, Young PK, Austin JV, Krumdieck CL et al (1990) The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis. Arthritis Rheum 33:9–18PubMedCrossRef
8.
Zurück zum Zitat van Ede AE, Laan RF, Rood MJ, Huizinga TW, van de Laar MA, van Denderen CJ et al (2001) Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum 44:1515–1524PubMedCrossRef van Ede AE, Laan RF, Rood MJ, Huizinga TW, van de Laar MA, van Denderen CJ et al (2001) Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum 44:1515–1524PubMedCrossRef
9.
Zurück zum Zitat Niehues T, Lankisch P (2006) Recommendations for the use of methotrexate in juvenile idiopathic arthritis. Paediatr Drugs 8:347–356PubMedCrossRef Niehues T, Lankisch P (2006) Recommendations for the use of methotrexate in juvenile idiopathic arthritis. Paediatr Drugs 8:347–356PubMedCrossRef
10.
Zurück zum Zitat Ravelli A, Migliavacca D, Viola S, Ruperto N, Pistorio A, Martini A (1999) Efficacy of folinic acid in reducing methotrexate toxicity in juvenile idiopathic arthritis. Clin Exp Rheumatol 17:625–627PubMed Ravelli A, Migliavacca D, Viola S, Ruperto N, Pistorio A, Martini A (1999) Efficacy of folinic acid in reducing methotrexate toxicity in juvenile idiopathic arthritis. Clin Exp Rheumatol 17:625–627PubMed
11.
Zurück zum Zitat Petty RE, Cassidy JT (2011) Chronic arthritis in childhood. In: Cassidy JT, Laxer RM (eds) Textbook of pediatric rheumatology. Saunders, Philadelphia, pp 211–235CrossRef Petty RE, Cassidy JT (2011) Chronic arthritis in childhood. In: Cassidy JT, Laxer RM (eds) Textbook of pediatric rheumatology. Saunders, Philadelphia, pp 211–235CrossRef
12.
Zurück zum Zitat Yaffe SJ (2010) Neonatal and pediatric pharmacology: therapeutic principles in practice. Lippincott Williams and Wilkins, Philadelphia Yaffe SJ (2010) Neonatal and pediatric pharmacology: therapeutic principles in practice. Lippincott Williams and Wilkins, Philadelphia
13.
Zurück zum Zitat Khanna D, Park GS, Paulus HE, Simpson KM, Elashoff D, Cohen SB et al (2005) Reduction of the efficacy of methotrexate by the use of folic acid: post hoc analysis from two randomized controlled studies. Arthritis Rheum 52:3030–3038PubMedCrossRef Khanna D, Park GS, Paulus HE, Simpson KM, Elashoff D, Cohen SB et al (2005) Reduction of the efficacy of methotrexate by the use of folic acid: post hoc analysis from two randomized controlled studies. Arthritis Rheum 52:3030–3038PubMedCrossRef
14.
Zurück zum Zitat Joyce DA, Will RK, Hoffman DM, Laing B, Blackbourn SJ (1991) Exacerbation of rheumatoid arthritis in patients treated with methotrexate after administration of folinic acid. Ann Rheum Dis 50:913–914PubMedCrossRef Joyce DA, Will RK, Hoffman DM, Laing B, Blackbourn SJ (1991) Exacerbation of rheumatoid arthritis in patients treated with methotrexate after administration of folinic acid. Ann Rheum Dis 50:913–914PubMedCrossRef
15.
Zurück zum Zitat Arabelovic S, Sam G, Dallal GE, Jacques PF, Selhub J, Rosenberg IH et al (2007) Preliminary evidence shows that folic acid fortification of the food supply is associated with higher methotrexate dosing in patients with rheumatoid arthritis. J Am Coll Nutr 26:453–455PubMedCrossRef Arabelovic S, Sam G, Dallal GE, Jacques PF, Selhub J, Rosenberg IH et al (2007) Preliminary evidence shows that folic acid fortification of the food supply is associated with higher methotrexate dosing in patients with rheumatoid arthritis. J Am Coll Nutr 26:453–455PubMedCrossRef
16.
Zurück zum Zitat Killeen OG, Gardner-Medwin JM (2006) In juvenile idiopathic arthritis, is folate supplementation effective against methotrexate toxicity at the expense of methotrexate’s efficacy? Arch Dis Child 91:537–538PubMedCrossRef Killeen OG, Gardner-Medwin JM (2006) In juvenile idiopathic arthritis, is folate supplementation effective against methotrexate toxicity at the expense of methotrexate’s efficacy? Arch Dis Child 91:537–538PubMedCrossRef
Metadaten
Titel
Folate usage in MTX-treated juvenile idiopathic arthritis (JIA) patients is inconsistent and highly variable
verfasst von
Gil Amarlilyo
Ornella J. Rullo
Deborah K. McCurdy
Jennifer M. P. Woo
Daniel E. Furst
Publikationsdatum
01.09.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Rheumatology International / Ausgabe 9/2013
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-013-2696-1

Weitere Artikel der Ausgabe 9/2013

Rheumatology International 9/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.